Trypsin 96 mg + Bromelain 180 mg + Rutoside Trihydrate 200 mg Enteric-Coated Tablet

Trypsin 96 mg + Bromelain 180 mg + Rutoside Trihydrate 200 mg Enteric-Coated Tablet is a enteric-coated tablet formulated with Trypsin 96 mg + Bromelain 180 mg + Rutoside Trihydrate 200 mg. The active ingredient profile is Trypsin; Bromelain; Rutoside Trihydrate, placing the product in the proteolytic enzyme combination category. Trypsin, Chymotrypsin, Bromelain and/or Rutoside components are used in enzyme-based anti-inflammatory or edema-support formulations, with activity dependent on the approved product specification. The enteric coating is intended to delay tablet disintegration until after passage through the stomach, subject to the approved finished-product specification. For website cataloguing, composition, strength, dosage form and release/coating characteristics should be displayed prominently and consistently. The description should remain factual and should not include unapproved cure, superiority, guaranteed-result or broad therapeutic claims. Clinical selection should depend on diagnosis, patient-specific factors, contraindications, concomitant medicines and the prescriber’s judgement. Prescription status, precautions, interactions, adverse effects and dosing must be checked against the current approved product label before publication. Manufacturer, licence, storage, shelf-life, pack configuration and market-specific regulatory details should be added only from verified product documentation.